» Articles » PMID: 15931815

Expression of P53 Protein and Primary Tumour Volume in Patients with Nasopharyngeal Carcinoma

Overview
Journal J Otolaryngol
Date 2005 Jun 4
PMID 15931815
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the relationship of p53 protein expression and primary tumour volume in patients with nasopharyngeal carcinoma.

Design: Retrospective study.

Setting: Tertiary care centre.

Method: Forty-two newly diagnosed patients participated in the study.

Main Outcome Measures: The relationship between p53 status, TNM stage, and computed tomography-derived primary tumour volume.

Results: In patients with high p53 stains, the tumour volume was larger (p = .03). p53 was found to be independent of clinical stage (p = .84).

Conclusion: There is a positive correlation between primary tumour volume and p53 status.

Citing Articles

Oncogene mutational profile in nasopharyngeal carcinoma.

Zhang Z, Fu S, Wang F, Wang H, Zeng Y, Shao J Onco Targets Ther. 2014; 7:457-67.

PMID: 24672248 PMC: 3964172. DOI: 10.2147/OTT.S58791.


Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers.

Tulalamba W, Janvilisri T Int J Cell Biol. 2012; 2012:594681.

PMID: 22500174 PMC: 3303613. DOI: 10.1155/2012/594681.


Primary tumor volume is an independent predictor of outcome within pT4a-staged tongue carcinoma.

Chen M, Chen C, Lee M, Chen L, Chen H Ann Surg Oncol. 2010; 18(5):1447-52.

PMID: 21174152 PMC: 3078304. DOI: 10.1245/s10434-010-1489-y.


NOLC1, an enhancer of nasopharyngeal carcinoma progression, is essential for TP53 to regulate MDM2 expression.

Hwang Y, Lu T, Huang D, Kuo Y, Kao C, Yeh N Am J Pathol. 2009; 175(1):342-54.

PMID: 19541936 PMC: 2708820. DOI: 10.2353/ajpath.2009.080931.


Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Chou J, Lin Y, Kim J, You L, Xu Z, He B Head Neck. 2008; 30(7):946-63.

PMID: 18446839 PMC: 3046044. DOI: 10.1002/hed.20833.